Yale University

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.

TitleThe immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
Publication TypeJournal Article
Year of Publication2012
AuthorsNaidoo, Kogieleum, Nonhlanhla Yende-Zuma, Nesri Padayatchi, Kasavan Naidoo, Niraksha Jithoo, Gonasagrie Nair, Sheila Bamber, Santhana Gengiah, Wafaa M. El-Sadr, Gerald Friedland, and Salim Abdool Karim
JournalAnnals of internal medicine
Volume157
Issue5
Pagination313-24
Date Published2012 Sep 4
ISSN1539-3704
KeywordsAdult, AIDS-Related Opportunistic Infections, Anti-Retroviral Agents, Antibiotics, Antitubercular, CD4 Lymphocyte Count, Female, HIV Infections, Humans, Immune Reconstitution Inflammatory Syndrome, Immunocompromised Host, Incidence, Kaplan-Meier Estimate, Male, Prospective Studies, Rifampin, Risk Factors, Severity of Illness Index, Tuberculosis
AbstractConcerns about the immune reconstitution inflammatory syndrome (IRIS) remain a barrier to antiretroviral therapy (ART) initiation during antituberculosis treatment in co-infected patients.
DOI10.1353/hpu.2012.0006
Alternate JournalAnn. Intern. Med.

External Links